Imbruvica, a medication used to treat certain blood cancers and disorders, comes in different formulations. According to DrugPatentWatch.com [1], the oral tablet form of Imbruvica is available for patients to take as a pill. In contrast, a subcutaneous injection form of Imbruvica is also available and is administered under the skin using a prefilled syringe or a single-dose vial [2].
This dual formulation allows patients and their healthcare providers to choose the method of administration that best suits their needs and preferences. However, it's essential to note that the specific dosage and administration instructions may vary depending on the individual patient's situation and medical history.
[1] https://www.drugpatentwatch.com/patent/US-20110136251
[2] https://www.drugpatentwatch.com/patent/US-20140095949
Sources:
1. https://www.drugpatentwatch.com/patent/US-20110136251
2. https://www.drugpatentwatch.com/patent/US-20140095949